Arcellx, Inc.
ACLXDelisted Apr 28, 2026- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001786205
Arcellx, Inc. was delisted on Apr 28, 2026; its insiders filed their last Form 4 on Apr 28, 2026; 240 institutions reported holding it in 13F filings for Q1 2026, worth $6.52B in total; Soros Fund Management was the only superinvestor holding it.
Q2 2025 vs. Q1 2025
How the institutions holding Arcellx, Inc. changed between Q1 2025 and Q2 2025.
All holders in Q2 2025All holders in Q1 2025
| Measure | Q1 2025 | Of which not filed for Q2 2025 | Q2 2025 | Change |
|---|---|---|---|---|
| Holders | 198 | 1 | 203 | +6 |
| Shares | 61.6M | 39 | 61.4M | −195.7K (−0.3%) |
| Value | $4.04B | $2.56K | $4.01B | −$32.5M (−0.8%) |
1 institution that held it in Q1 2025 haven't filed for Q2 2025 yet. Not filing isn't selling, so the changes leave them out.
New holders (30)
Institutions that held Arcellx, Inc. at the end of Q2 2025 but not at the end of Q1 2025.
Sold out (24)
Institutions that held Arcellx, Inc. at the end of Q1 2025 and filed for Q2 2025 without it.
| Institution | Shares, Q1 2025 | Value, Q1 2025 |
|---|---|---|
| Artia Global Partners LP | 229,085 | $15.0M |
| Candriam Luxembourg S.C.A. | 70,538 | $4.63M |
| Renaissance Technologies LLC | 68,000 | $4.46M |
| First Trust Advisors LP | 67,201 | $4.41M |
| Readystate Asset Management LP | 45,058 | $2.96M |
| Empowered Funds, LLC | 26,954 | $1.77M |
| Corebridge Financial, Inc. | 21,428 | $1.41M |
| PFM Health Sciences, LP | 15,488 | $1.02M |
| Verition Fund Management LLC | 8,880 | $582.5K |
| Allspring Global Investments Holdings, LLC | 7,702 | $467.5K |
| Two Sigma Investments, LP | 6,900 | $452.6K |
| HSBC Holdings PLC | 5,074 | $310.6K |
| Neo Ivy Capital Management | 3,948 | $259.0K |
| Principal Financial Group Inc | 3,495 | $229.3K |
| SIH Partners, LLLP | 3,461 | $227.0K |
| Mercer Global Advisors Inc | 3,302 | $216.6K |
| Xponance, Inc. | 3,278 | $215.0K |
| Exchange Traded Concepts, LLC | 1,751 | $114.9K |
| BI Asset Management Fondsmaeglerselskab A/S | 761 | $50.0K |
| Coldstream Capital Management Inc | 124 | $8.13K |
| Caitong International Asset Management Co., Ltd | 27 | $1.77K |
| Sierra Ocean, LLC | 16 | $1.05K |
| Stephens Consulting, LLC | 15 | $984 |
| Principal Securities, Inc. | 3 | $230 |
Not filed for Q2 2025 yet (1)
Institutions that held Arcellx, Inc. at the end of Q1 2025 and haven't filed a 13F for Q2 2025. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q1 2025 | Value, Q1 2025 |
|---|---|---|
| Lindbrook Capital, LLC | 39 | $2.56K |